Alcon (ALC) Net Margin (2009 - 2026)

Alcon (ALC) posted Net Margin of 15.46% for Q1 2026, up 9.33% on a QoQ basis from 14.14% in Q4 2025.

Analysis

Alcon (ALC) Net Margin (2009 - 2026) Analysis & Trends

Alcon has reported Net Margin for 11 years, with the latest figure at 15.46% in Q1 2026.

On a quarterly basis, Net Margin changed N/A year-over-year to 15.46% in Q1 2026; TTM through Jun 2026 was 11.07%, a 57.0% decrease from a year earlier, with the FY2025 full-year figure at 14.74%, down 66.0% from the prior year.
Net Margin was 15.46% for Q1 2026 at Alcon, up from 14.14% in the prior quarter.
The five-year high for Net Margin was 16.52% in Q3 2024, with the low at 3.9% in Q4 2023.
Average Net Margin over 5 years is 10.23%, with a median of 10.66% recorded in 2023.
The sharpest annual moves came in 2023 and 2024: Net Margin slumped 551 bps in 2023, then soared 1840 bps in 2024.
Over 5 years, Net Margin stood at 1.61% in 2022, then plunged by 342 bps to 3.9% in 2023, then jumped by 471 bps to 14.49% in 2024, then fell by 2 bps to 14.14% in 2025, then gained by 9 bps to 15.46% in 2026.
The last three Net Margin figures came in at 15.46% (Q1 2026), 14.14% (Q4 2025), and 15.22% (Q3 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Abbott Laboratories	181.19 Bn	175.58 Bn	7.27 Bn	7.37%
2	Intuitive Surgical	127.77 Bn	122.55 Bn	1.96 Bn	28.46%
3	Medtronic	117.13 Bn	108.31 Bn	6.34 Bn	15.17%
4	Stryker	104.67 Bn	101.20 Bn	4.50 Bn	19.37%
5	Boston Scientific	64.48 Bn	63.94 Bn	3.85 Bn	16.67%
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn	13.87%
7	Alcon	33.06 Bn	31.61 Bn	1.68 Bn	-
8	Dexcom	32.37 Bn	30.43 Bn	830.00 Mn	19.04%
9	Steris	20.76 Bn	20.28 Bn	684.20 Mn	13.47%
10	Zimmer Biomet Holdings	17.71 Bn	17.30 Bn	1.54 Bn	9.17%

Historic Data

Download Data